1-(3-(trifluoromethyl)phenyl)cyclobutane-1-carboxamide | 29786-53-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(3-(trifluoromethyl)phenyl)cyclobutane-1-carboxamide
• 英文别名: 1-(α,α,α-Trifluor-m-tolyl)cyclobutancarboxamid；1-[3-(Trifluoromethyl)phenyl]cyclobutane-1-carboxamide；1-[3-(trifluoromethyl)phenyl]cyclobutane-1-carboxamide
• CAS: 29786-53-6
• 化学式: C₁₂H₁₂F₃NO
• 分子量: 243.229
• InChiKey: MQXYWUCPPPWCPX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-(3-(trifluoromethyl)phenyl)cyclobutane-1-carboxamide 生成 (<1-(α,α,α-Trifluoro-m-tolyl)cyclobutyl>carbonyl)carbamsaeuremethylester
  参考文献：
  名称：

  (1-arylcyclobutyl)carbonyl carbamic acid derivatives

  摘要：

  公开号：

  US03526656A1
• 作为产物：
  描述：

  1-[3-(三氟甲基)苯基]环丁烷-1-腈 在 四丁基溴化铵 、 双氧水 、 sodium hydroxide 作用下， 以 甲醇 为溶剂， 反应 18.0h， 以98%的产率得到1-(3-(trifluoromethyl)phenyl)cyclobutane-1-carboxamide
  参考文献：
  名称：

  KR2017/43091

  摘要：

  公开号：

文献信息

• A Hofmann Rearrangement-Ring Expansion Cascade for the Synthesis of 1-Pyrrolines: Application to the Synthesis of 2,3-Dihydro-1<i>H</i>-pyrrolo[2,1-<i>a</i>]isoquinolinium Salts
  作者：He Huang、Qinghua Yang、Qianqian Zhang、Jie Wu、Yizhen Liu、Chuanjun Song、Junbiao Chang

  DOI：10.1002/adsc.201501071

  日期：2016.3.31

  cyclobutanecarboxamide with bis(trifluoroacetoxy)iodobenzene, PhI(OCOCF3)2, resulted in the formation of 1‐pyrroline via Hofmann rearrangement of the former followed by in situ ring expansion reaction of the cyclobutylamine intermediate. Further elaboration of this methodology to the synthesis of 2,3‐dihydro‐1H‐pyrrolo[2,1‐a]isoquinolinium salts has also been described.

  用双（三氟乙酰氧基）碘苯PhI（OCOCF 3）2处理环丁烷甲酰胺，导致前者的霍夫曼重排形成1-吡咯啉，然后环丁胺中间体进行原位环扩环反应。还描述了该方法对2,3-二氢-1 H-吡咯并[2,1- a ]异喹啉鎓盐的合成的进一步阐述。
• OXADIAZOLE AMINE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
  申请人：Chong Kun Dang Pharmaceutical Corp.

  公开号：EP3362445A1

  公开（公告）日：2018-08-22
• [EN] OXADIAZOLE AMINE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME<br/>[FR] COMPOSÉS DÉRIVÉS D'OXADIAZOLE AMINE UTILISÉS EN TANT QU'INHIBITEUR DE L'HISTONE DÉSACÉTYLASE 6, ET COMPOSITION PHARMACEUTIQUE LES COMPRENANT
  申请人：CHONG KUN DANG PHARMACEUTICAL CORP

  公开号：WO2017065473A1

  公开（公告）日：2017-04-20

  The present disclosure relates to novel compounds having histone deacetylase 6 (HDAC6) inhibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof, the use thereof for the preparation of therapeutic medicaments, pharmaceutical compositions containing the same, a method for treating diseases using the composition, and methods for preparing the novel compounds. The novel compounds, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present disclosure have histone deacetylase (HDAC) inhibitory activity and are effective for the prevention or treatment of HDAC6-mediated diseases, including infectious diseases; neoplasms; endocrine, nutritional and metabolic diseases; mental and behavioral disorders; neurological diseases; diseases of the eye and adnexa; cardiovascular diseases; respiratory diseases; digestive diseases; diseases of the skin and subcutaneous tissue; diseases of the musculoskeletal system and connective tissue; or congenital malformations, deformations and chromosomal abnormalities.